Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Payables (2019 - 2026)

Cresco Labs filings provide 8 years of Payables readings, the most recent being $14.2 million for Q1 2026.

  • On a quarterly basis, Payables changed N/A to $14.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $14.2 million, a N/A change, with the full-year FY2025 number at $27.3 million, changed N/A from a year prior.
  • Payables hit $14.2 million in Q1 2026 for Cresco Labs, down from $27.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $56.3 million in Q2 2022 to a low of $14.2 million in Q1 2026.
  • Median Payables over the past 5 years was $37.7 million (2022), compared with a mean of $36.0 million.
  • Biggest five-year swings in Payables: skyrocketed 503.28% in 2022 and later crashed 44.01% in 2023.
  • Cresco Labs' Payables stood at $43.5 million in 2022, then fell by 9.48% to $39.4 million in 2023, then rose by 5.09% to $41.4 million in 2024, then tumbled by 34.02% to $27.3 million in 2025, then plummeted by 48.13% to $14.2 million in 2026.
  • The last three reported values for Payables were $14.2 million (Q1 2026), $27.3 million (Q4 2025), and $41.4 million (Q3 2024) per Business Quant data.